The complaint claims that the state illegally changed rules regarding income eligibility thresholds for the AIDS Drug ...
A state administrative court is being asked to put the brakes on a move by the DeSantis administration to shore up an alleged $120 million funding deficit in an HIV/AIDS program by paring back program ...
Indiana lawmakers advanced a bill this week to extend approval for syringe services programs another decade. It’s set to ...
Medicare selected Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...
The source of the contamination, however, is not yet known. Both companies and the U.S. Food and Drug Administration emphasized that the investigation into the unprecedented outbreak that has sickened ...
Altimmune stock: 48-week pemvidutide MASH data, FDA Breakthrough Therapy boost, but rising competition and cash needs. Click ...
The U.S. FDA’s device center posted a report on the TAP program, stating that the metrics available to date suggest the ...
The discovery of a tumor in a patient who received REGENXBIO’s gene therapy for Hurler syndrome prompted the FDA to place a hold on that program along with the company’s Hunter syndrome program, which ...
The U.S. plans to negotiate the prices of 15 more medications covered by Medicare, including two of Eli Lilly's top-selling drugs - though there were few surprises. The Centers for Medicare and ...
Shares of Regenxbio plunged after the Food and Drug Administration placed clinical holds on two drug development programs ...
The second round of price negotiations covered 15 drugs and included household names such as semaglutide (Ozempic, Rybelsus, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results